RaySearch Adjusts Voting Structure After Major Class A to B Share Conversion

RaySearch Laboratories AB ( ($SE:RAY.B) ) just unveiled an announcement.

RaySearch Laboratories has reported a change in its share capital structure following the conversion of 2,171,738 Class A shares into an equal number of Class B shares during December. After the conversion, the company’s total number of shares remains 34,282,773, now comprising 3,483,237 Class A shares and 30,799,536 Class B shares, resulting in a total of 65,631,906 votes. The shift reduces the proportion of high-vote Class A shares, slightly altering the company’s voting dynamics and potentially broadening the influence of holders of the more widely traded Class B shares, though without affecting overall share count or immediate operations.

The most recent analyst rating on ($SE:RAY.B) stock is a Buy with a SEK255.00 price target. To see the full list of analyst forecasts on RaySearch Laboratories AB stock, see the SE:RAY.B Stock Forecast page.

More about RaySearch Laboratories AB

RaySearch Laboratories AB is a Stockholm-based medical technology company that develops advanced software for improved cancer treatment. Its portfolio includes the RayStation treatment planning system, the RayCare oncology information system, the RayIntelligence oncology analytics platform, and the RayCommand treatment control system, with software installed at more than 1,100 clinics in 47 countries. Founded in 2000 as a spin-off from the Karolinska Institute, RaySearch has been listed on Nasdaq Stockholm since 2003.

Average Trading Volume: 151,809

Technical Sentiment Signal: Buy

Current Market Cap: SEK7.7B

See more insights into RAY.B stock on TipRanks’ Stock Analysis page.